BSE filing, BSE: 543410. Summary written from the filing by ALFA Finder's alert engine.
DMR Engineering Ltd: key numbers
- Share price
- ₹32.57
- Market cap
- ₹33.78 Cr
- Revenue (annual)
- ₹12.54 Cr
- Net profit (annual)
- ₹1.40 Cr
- P/E (TTM)
- 24.1×Sector 43.1×
- Promoter holding
- 69.90%
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from DMR Engineering Ltd
All →DMR Engineering Results Update
DMR Engineering reported H1 FY26-27 standalone revenue of ₹876.19 lakhs and PAT of ₹224.95 lakhs, up sharply YoY. Management highlighted its largest EPC contract and Bhutan subsidiary expansion.
DMR Engineering H1 FY27 Results: Net Profit ₹2.3 Cr, Up 27.8% YoY
DMR Engineering Ltd reported revenue from operations of ₹9.8 Cr (+28.9% YoY) and net profit of ₹2.3 Cr (+27.8% YoY) for H1 FY27.
- Key figure
- Net profit ₹2.3 Cr · +27.8% YoY
DMR Engineering Bags ₹2.05 Cr Order from Studio Ing. G. Pietrangeli Srl
DMR Engineering received an assignment from Studio Ing. G. Pietrangeli Srl for ADB/DPN Nagaland consultancy services. Contract value is USD 216,000 (~₹2.05 Crore) over 12 months.
- Value
- ₹2.05 Cr
- From
- Studio Ing. G. Pietrangeli Srl
- Execution
- 12 months
DMR Engineering Board Meeting Date
DMR Engineering scheduled its board meeting for October 23, 2026, to approve H1 FY27 results. No financial figures are disclosed at this stage.
DMR Engineering Other Announcement
DMR Engineering Ltd has filed its quarterly shareholding pattern as of September 30, 2026, disclosing the distribution of equity shares among various stakeholder categories.
DMR Engineering Merger & Restructuring Worth ₹0.01 Cr
DMR Engineering incorporated a new subsidiary, DMR BALAJI JV PRIVATE LIMITED, acquiring a 51% stake for a cash consideration of ₹0.0051 Crore.
- Value
- ₹0.01 Cr
Other other announcement announcements
All →Prism Medico and Pharmacy Other Announcement
Prism Medico and Pharmacy intimated BSE and MSEI that its corporate website is updated and functional per Regulation 46. This is a routine compliance undertaking with no financial impact.
Banaras Beads Other Announcement
Banaras Beads Ltd filed its half-year related-party transaction disclosure under Listing Regulation 23(9). The filing reports routine remuneration and sitting fees to promoters and directors.
Gita Renewable Energy Other Announcement
Gita Renewable Energy intimated a change in its CIN after altering its Objects Clause. The change followed a Special Resolution at its 16th AGM.
Indian Toners & Developers Other Announcement
Indian Toners & Developers has intimated that NSE approved listing of its 5.19 crore equity shares (₹2 face value) on the NSE Mainboard effective October 30, 2026. This is an additional-exchange admission of already-issued BSE-listed shares.
Indian Phosphate Other Announcement
Indian Phosphate filed a Reg 27(2) governance non-applicability certificate for Q1 FY2027. The routine compliance filing carries no transaction or financial impact.
Neuland Laboratories Other Announcement
Neuland Laboratories notified loss of 100 share certificates by shareholder Madan Mohan Singh. The company requested issuance of an entitlement letter in lieu of the lost certificates.